Omadacycline Recommended by FDA Panel for ABSSSI and CABP

15:49 EDT 10 Aug 2018 | Medscape

An FDA panel recommended omadacycline for acute bacterial skin and skin structure infections and community-acquired bacterial pneumonia.
Medscape Medical News

Original Article: Omadacycline Recommended by FDA Panel for ABSSSI and CABP


More From BioPortfolio on "Omadacycline Recommended by FDA Panel for ABSSSI and CABP"

Quick Search


Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Acne Dermatology Eczema Psoriasis Wound Care Dermatology is the medical specialty concerned with the diagnosis and treatment of skin disorders (Oxford Medical Dictionary). As well as studying how the skin works, dermatology covers...

Wound management
Anything that breaks the skin is a wound because when the skin is broken, there's a risk of germs getting into the body and causing an infection. Follow and track Wound Care News on BioPortfolio: Wound Car...